Mail

UK markets close in 7 hours 22 minutes

FTSE 100
8,423.51
+42.16(+0.50%)
FTSE 250
20,598.75
+67.45(+0.33%)
AIM
785.70
+2.00(+0.26%)
GBP/EUR
1.1620
+0.0009(+0.08%)
GBP/USD
1.2527
+0.0003(+0.02%)
Bitcoin GBP
50,303.98
+1,350.44(+2.76%)

Homes with investment potential

These residential properties could bring in a good ROI

Sino Biopharmaceutical Limited (SBHMY)

Other OTC - Other OTC Delayed price. Currency in USD

Add to watchlist

7.20

0.00

(0.00%)

At close: 11:14AM EDT

Currency in USD

Valuation measures⁴

Market cap (intra-day)	6.99B
Enterprise value	6.78B
Trailing P/E	25.00
Forward P/E	18.80
PEG ratio (5-yr expected)	N/A
Price/sales (ttm)	1.81
Price/book (mrq)	1.57
Enterprise value/revenue	0.26
Enterprise value/EBITDA	0.97

Trading information

Stock price history

Beta (5Y monthly)	0.54
52-week change ³	-30.77%
S&P500 52-week change ³	26.43%
52-week high ³	10.40
52-week low ³	6.68
50-day moving average ³	7.53
200-day moving average ³	8.03

Share statistics

Avg vol (3-month) ³	314
Avg vol (10-day) ³	N/A
Shares outstanding ⁵	939.56M
Implied shares outstanding ⁶	957.57M
Float ⁸	9.28B
% held by insiders ¹	0.00%
% held by institutions ¹	0.00%
Shares short ⁴	N/A
Short ratio ⁴	N/A
Short % of float ⁴	N/A
Short % of shares outstanding ⁴	N/A
Shares short (prior month ) ⁴	N/A

Dividends & splits

Forward annual dividend rate ⁴	0.36
Forward annual dividend yield ⁴	4.97%
Trailing annual dividend rate ³	0.05
Trailing annual dividend yield ³	0.63%
5-year average dividend yield ⁴	1.63
Payout ratio ⁴	72.83%
Dividend date ³	13 Nov 2023
Ex-dividend date ⁴	04 Oct 2023
Last split factor ²	1.5:1
Last split date ³	14 Aug 2020

Financial highlights

Currency in CNY.

Fiscal year

Fiscal year ends	31 Dec 2023
Most-recent quarter (mrq)	31 Dec 2023

Profitability

Profit margin	8.90%
Operating margin (ttm)	20.76%

Management effectiveness

Return on assets (ttm)	5.33%
Return on equity (ttm)	12.12%

Income statement

Revenue (ttm)	26.2B
Revenue per share (ttm)	28.28
Quarterly revenue growth (yoy)	N/A
Gross profit (ttm)	N/A
EBITDA	6.38B
Net income avi to common (ttm)	1.85B
Diluted EPS (ttm)	0.29
Quarterly earnings growth (yoy)	N/A

Balance sheet

Total cash (mrq)	14.12B
Total cash per share (mrq)	0.77
Total debt (mrq)	12.72B
Total debt/equity (mrq)	33.31%
Current ratio (mrq)	1.05
Book value per share (mrq)	1.66

Cash flow statement

Operating cash flow (ttm)	6.07B
Levered free cash flow (ttm)	3.01B